There is no clear and unified statistical value for the cure rate of hepatitis B virus-associated nephritis, and its cure rate is closely related to the clinical manifestations of the patient, the pathological type of the kidney and the sensitivity of the treatment, so it cannot be generalized. Hepatitis B virus-associated nephritis is a glomerular disease associated with hepatitis B virus infection, and it is a common extrahepatic complication of hepatitis B virus infection. Most patients often present with proteinuria or nephrotic syndrome. Renal function may be normal at the onset of the disease, and the manifestations of liver disease vary, ranging from asymptomatic carriers to chronic hepatitis. China has a high prevalence of hepatitis B virus infection, which leads to a high incidence of hepatitis B virus-associated nephritis. Its cure rate is usually influenced by the clinical manifestations of the disease, the pathological type of the kidney, and the sensitivity to treatment. When the clinical symptoms of hepatitis B virus-associated nephritis are severe and the pathologic type is mesangial capillary glomerulonephritis, severe mesangial proliferative glomerulonephritis, and the treatment is not sensitive, the cure rate is often low and the prognosis is poor. There is no clear conclusion on the cure rate of hepatitis B virus-associated nephritis. It is recommended that patients with hepatitis B virus-associated nephritis should go to regular hospitals in time and receive standardized treatment under the guidance of doctors.